Cases of adverse reaction to psychotropic drugs and possible association with pharmacogenetics.
Ontology highlight
ABSTRACT: Thousands of samples for pharmacogenetic tests have been analysed in our laboratory since its establishment. In this article we describe some of the most interesting cases of CYP poor metabolisers associated with adverse reactions to psychotropic drugs. Prevention of disease/illness, including Adverse Drug Reaction (ADR), is an aim of modern medicine. Scientific data supports the fact that evaluation of drug toxicology includes several factors, one of which is genetic variations in pharmacodynamics and pharmacokinetics of drug pathways. These variations are only a part of toxicity evaluation, however, even if it would help to prevent only a small percentage of patients from suffering adverse drug reactions, especially life threatening ADRs, pharmacogenetic testing should play a significant
SUBMITTER: Piatkov I
PROVIDER: S-EPMC4251377 | biostudies-literature | 2012 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA